ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.96
0.71%
US Tech 100
20,762.73
1.73%
S&P 500
5,942.47
1.26%
US Dollar vs CAD
1.44457
0.00%
Bitcoin
98,264.97
0.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Anheuser Busch InBev SA NV (1ABI) Share Price

Anheuser Busch InBev SA NV

Anheuser Busch InBev SA NV (1ABI)

BIT
47.68
-1.08
(-2.21%)
Closed January 05 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
47.68
Bid
46.82
Ask
57.00
Volume
51
47.68 Day's Range 48.51
47.68 52 Week Range 61.98
Market Cap
39.888B
Previous Close
48.76
Open
48.51
Last Trade
21
@
47.68
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
225
Shares Outstanding
836,569,710
Dividend Yield
1.72%
PE Ratio
7.42
Earnings Per Share (EPS)
6.38
Revenue
59.38B
Net Profit
5.34B

About Anheuser Busch InBev SA NV

Sector
Malt Beverages
Industry
Malt Beverages
Website
www.ab-inbev.com
Headquarters
Leuven, Flemish Brabant, Bel
Founded
-
Anheuser Busch InBev SA NV is listed in the Malt Beverages sector of the Italian Stock Exchange with ticker 1ABI. The last closing price for Anheuser Busch InBev SA NV was 48.76 €. Over the last year, Anheuser Busch InBev SA NV shares have traded in a share price range of 47.68 € to 61.98 €.

Anheuser Busch InBev SA NV currently has 836,569,710 shares outstanding. The market capitalization of Anheuser Busch InBev SA NV is 40.79 € billion. Anheuser Busch InBev SA NV has a price to earnings ratio (PE ratio) of 7.42.

Ask ADVFN Intelligence (AI)

1ABI Latest News

More News

AB InBev 100+ Accelerator partners with The Coca-Cola Company, Colgate-Palmolive and Unilever for Sustainable Startup Innovat...

AB InBev 100+ Accelerator partners with The Coca-Cola Company, Colgate-Palmolive and Unilever for Sustainable Startup Innovation NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Today, The...

April 22 2021
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4-0.83194675540848.0848.7647.685848.08283237DE
4-2.86-5.6588840522450.5451.5247.6810949.79104987DE
12-11.36-19.241192411959.0460.7247.6822552.29863591DE
26-7.66-13.841705818655.3460.947.6826555.25957401DE
52-11.41-19.309527838959.0961.9847.6822056.34861991DE
156-6.97-12.753888380654.6561.9845.7629754.64678042DE
260-26.67-35.870880968474.357530.2345552.18672834DE

1ABI - Frequently Asked Questions (FAQ)

What is the current Anheuser Busch InBev SA NV share price?
The current share price of Anheuser Busch InBev SA NV is 47.68 €
How many Anheuser Busch InBev SA NV shares are in issue?
Anheuser Busch InBev SA NV has 836,569,710 shares in issue
What is the market cap of Anheuser Busch InBev SA NV?
The market capitalisation of Anheuser Busch InBev SA NV is EUR 40.79B
What is the 1 year trading range for Anheuser Busch InBev SA NV share price?
Anheuser Busch InBev SA NV has traded in the range of 47.68 € to 61.98 € during the past year
What is the PE ratio of Anheuser Busch InBev SA NV?
The price to earnings ratio of Anheuser Busch InBev SA NV is 7.42
What is the cash to sales ratio of Anheuser Busch InBev SA NV?
The cash to sales ratio of Anheuser Busch InBev SA NV is 0.67
What is the reporting currency for Anheuser Busch InBev SA NV?
Anheuser Busch InBev SA NV reports financial results in USD
What is the latest annual turnover for Anheuser Busch InBev SA NV?
The latest annual turnover of Anheuser Busch InBev SA NV is USD 59.38B
What is the latest annual profit for Anheuser Busch InBev SA NV?
The latest annual profit of Anheuser Busch InBev SA NV is USD 5.34B
What is the registered address of Anheuser Busch InBev SA NV?
The registered address for Anheuser Busch InBev SA NV is BROUWERIJPLEIN, 1, LEUVEN, FLEMISH BRABANT, 3000
What is the Anheuser Busch InBev SA NV website address?
The website address for Anheuser Busch InBev SA NV is www.ab-inbev.com
Which industry sector does Anheuser Busch InBev SA NV operate in?
Anheuser Busch InBev SA NV operates in the MALT BEVERAGES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WAMB26Ambromobiliare SpA
0.098 €
(96.00%)
53.83k
1NBNorthern Data AG
52.50 €
(30.76%)
34
EVAAskoll Eva SPA
0.17 €
(25.46%)
403k
WSOGESWarr Soges Group
0.115 €
(21.05%)
15k
WTFINTrevi Finanziaria Industriale Spa
0.89 €
(18.67%)
3.33k
WCOSMOFarmacosmo spa
0.0096 €
(-67.89%)
6.67k
COSMOFarmacosmo spa
0.668 €
(-22.86%)
338.93k
WTWL26TraWell Co SpA
0.22 €
(-21.43%)
600
GTGT Talent Group SpA
2.76 €
(-14.29%)
21.38k
WSGC28SG Company SpA
0.025 €
(-12.89%)
12.26k
TITTelecom Italia SpA
0.243 €
(-2.68%)
128.24M
ISPIntesa Sanpaolo Spa
3.849 €
(-0.03%)
47.15M
SPMSaipem Spa
2.717 €
(2.07%)
44.36M
ENELEnel Spa
7.023 €
(-0.03%)
14.4M
BPEBper Banca SPA
5.90 €
(-0.94%)
11.78M

Discussion

View Full Feed
DonVance DonVance 3 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 4 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 4 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 5 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 7 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 8 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 9 minutes ago
Not good, thanks for sharing.
sand sand 16 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 16 minutes ago
Moving hard soon 
EFSH
mining101 mining101 17 minutes ago
Superb
MEGL
benz280c benz280c 25 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 31 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 32 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 35 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 41 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 41 minutes ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 46 minutes ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 48 minutes ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 49 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 51 minutes ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 54 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 57 minutes ago
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 58 minutes ago
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO

Your Recent History

BIT
1ABI
Anheuser Busch InBev SA NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads